The radiotheranostics market is rapidly growing, driven by advancements in nuclear medicine and personalized healthcare. Combining diagnostics and therapy, radiotheranostics offers precise cancer treatment while minimizing side effects. Increasing prevalence of cancer, rising demand for targeted treatments, and ongoing innovation in radiopharmaceuticals fuel market expansion, enhancing patient outcomes globally. Visit us: https://www.imarcgroup.com/radiotheranostics-market